Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

8.48

-0.12 (-1.40%)

At close: Aug 28, 2026, 4:00 PM EDT

8.60

+0.12 (1.42%)

After-hours: Aug 28, 2026, 7:57 PM EDT

Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,546	1,303	505	325	181	365
Market Cap Growth	19.83%	157.72%	55.70%	79.47%	-50.50%	-
Enterprise Value	1,714	1,469	707	487	226	360
Last Close Price	8.48	7.85	3.39	2.35	1.33	2.93

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	2351.09	-	-	-	-
Forward PE	47.11	64.50	-	-	-	-
PS Ratio	4.61	4.46	2.49	1.98	1.64	7.37
PB Ratio	-	95.15	-17.07	-47.86	4.00	3.84
P/FCF Ratio	27.77	46.64	-	-	-	-
P/OCF Ratio	27.31	45.50	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.11	5.03	3.48	2.97	2.05	7.26
EV/EBITDA Ratio	35.14	39.64	-	-	-	-
EV/EBIT Ratio	46.83	58.99	-	-	-	-
EV/FCF Ratio	30.78	52.58	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-29.73	18.85	-9.17	-33.79	4.38	0.93
Debt / EBITDA Ratio	5.10	5.73	-	-	-	-
Debt / FCF Ratio	5.20	9.24	-	-	-	-
Net Debt / Equity Ratio	-17.23	10.74	-6.75	-23.11	1.68	-0.15
Net Debt / EBITDA Ratio	3.44	3.97	-9.26	-4.95	-1.09	0.14
Net Debt / FCF Ratio	3.01	5.27	-5.28	-3.18	-0.74	0.15
Asset Turnover	0.90	0.83	0.63	0.49	0.34	0.21
Inventory Turnover	0.61	0.73	0.85	0.90	1.06	1.01
Quick Ratio	0.95	1.48	1.12	1.17	2.08	1.52
Current Ratio	1.45	2.19	1.67	1.64	2.54	1.80
Return on Equity (ROE)	-	-	-	-324.20%	-134.83%	-190.28%
Return on Assets (ROA)	6.13%	4.40%	-6.51%	-8.25%	-15.78%	-28.45%
Return on Capital Employed (ROCE)	16.50%	9.10%	-15.10%	-19.40%	-30.20%	-46.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-1.11%	0.04%	-10.85%	-19.18%	-52.34%	-33.59%
FCF Yield	3.60%	2.14%	-7.49%	-15.18%	-57.18%	-26.44%
Buyback Yield / Dilution	-10.29%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%

SEC Filings: 10-K · 10-Q